NCT00652392View on ClinicalTrials.gov

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

June 30, 2004

Conditions
Asthma
Interventions
DRUG

budesonide/formoterol

DRUG

budesonide and placebo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY